AI researchers hope to ID healthcare workers with COVID-19 before they show symptoms

Researchers from West Virginia University (WVU) have launched a new study aimed at identifying healthcare workers infected with the new coronavirus before they become symptomatic. The project is a collaboration between WVU and Oura Health, a smart-ring technology company that specializes in tracking the sleep and daily activities of its users.

The team is using an advanced AI model and Oura Health’s wearable ring technology to track physicians, nurses and other healthcare providers throughout West Virginia. Data is also being gathered from healthcare workers exposed to COVID-19 in U.S. cities such as New York City and Philadelphia.

The goal is to ultimately detect when providers are infected with the virus as quickly as possible, limiting their ability to potentially spread COVID-19 to their colleagues, patients and loved ones back home.

“We are continuously monitoring the mind-body connectivity through our integrated neuroscience platform measuring the autonomic nervous system, fatigue, anxiety, circadian rhythms, and other human resilience and recovery functions,” Ali Rezai, MD, executive chair of the WVU Rockefeller Neuroscience Institute, said in a prepared statement. “Our AI-driven models are currently predicting symptoms 24 hours prior to onset, and we are working toward a three-plus day forecast. This forecasting capability will help us get ahead of this pandemic; limit the spread to protect healthcare workers, their families, and our communities; and improve our understanding of health recovery.” 

“At Oura, we’ve heard firsthand from our users how the physiological signals tracked by the ring have predicted the onset of the virus before other symptoms manifest,” Harpreet Rai, CEO of Oura Health, said in the same statement. “We’re grateful we can apply this knowledge to help vulnerable caregivers swiftly identify the earliest signs of the disease, and take the appropriate protective measures to limit its spread.”  

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.